3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Solid Tumor
4
Rectal Neoplasms
4
Neoplasms
3
Lymphoma
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Thromboembolism
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma, Testicular
1
Teratoma
1
Spinal Cord Neoplasms
1
Seminoma
1
Interventions
enoxaparin sodium
1
Warfarin
1
Sodium Bicarbonate
1
Saline Solution
1
Pentetic Acid
1
PEGPH20
1
Minocycline
1
Heparin
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Fluoridation
1
Enoxaparin
1
Aspirin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thromboembolism
×
Fluorodeoxyglucose F18
×
Clear all
NCT00964275
2014-12-08
MVTEP
University Hospital, Brest
Phase NA
Completed
400 enrolled